+44 (0)191 640 3638
enquiries@onyxhealth.com
Generator Studios
Trafalgar Street
Newcastle-upon-Tyne
NE1 2LA
We aim to shed light on the importance of early diagnosis, effective management, and treatment of sialorrhoea, emphasising its significant impact on quality of life.
Learn More
Collaborating with influential UK and EU chemotherapy nurses, we developed a robust medical education program in order to train nurses in extravasation management.
Learn More
Sialorrhoea is an often overlooked symptom of neurological disorders in children, yet it can have a profound impact on their lives as it can lead to social exclusion and discomfort. “This is Sialorrhoea” aimed to increase awareness of the condition and improve the lives of patients experiencing it.
Learn More
Endometriosis is a condition often overlooked by HCPs and frequently dismissed by society as a pain women have to simply ‘put up with’. We wanted to highlight the severity of the problem of mistreated and misdiagnosed patients using Endometriosis Awareness Month and use Onyx Health’s position as a springboard to create change.
Learn More
The cardiovascular treatment and prevention pathway is well established, but with relatively little innovation, keeping treatments front of mind was challenging. There is a grey area in current risk reduction guidelines, where clinicians require more guidance when making prescribing decisions.
Learn More
Amarin Corporation, a mid-sized pharmaceutical company from the US, was on the brink of receiving EMA approval for its drug, prompting its decision to go it alone and establish a European presence. With plans to operate in 12 markets, Amarin faced the challenge of low awareness in Europe. Building a reputation was crucial for rapid expansion which the company set out to do within a year.
Learn More
Following a new indication for an oral solution used to treat severe paediatric hypersalivation, Colonis Pharma Limited approached Onyx Health to create a full two-phase launch strategy and a library of materials to accompany the launch.
Learn More
Despite its global achievements in value-added medicines (VAMs), Colonis had long been concealed within its parent company. The lack of brand recognition posed significant obstacles to its growth and market presence. The challenge was clear: to reposition Colonis as a leading player in VAMs, boost its visibility and differentiate it effectively from competitors.
Learn More
We were approached by a global pharma company to help promote their antihistamine product to HCPs. The aim was to communicate the allergy relief benefits for children and adolescents, when compared to competitor products, and drive HCP recommendations
Learn More
SAFIRA, a tool born from medical device innovation, that improves anaesthetic delivery by regulating the pressure by which anaesthetic is administered for regional anaesthesia, was set to launch in the US. Our client, Medovate, wanted a creative concept and marketing assets to generate interest at a medical congress, but due to COVID-19, the congress was cancelled and we needed to adapt.
Learn More
Actigen wanted to establish themselves as an expert partner prior to the launch of their first clinical trial.
Learn More
Managing sickle cell disease in children is challenging, due to various factors such as cultural, societal, and parental concerns. These factors often hinder early treatment initiation, despite the well-documented long-term benefits. Medication adherence also poses a significant challenge once treatment has commenced.
Learn More
Zilico’s flagship product ZedScan, can identify potential areas of disease in the cervix earlier than traditional colposcopy methods, which have remained relatively unchanged for decades. Messaging needed to be carefully considered so as not to alienate colposcopists by suggesting they were misdiagnosing.
Learn More
Faced with the challenge of attracting investment on a global scale, a pharmaceutical company working in the field of rare diseases approached us to guide their efforts. The company was seeking partners in India, China, the UK and the US, but required direction in their first foray into digital marketing.
Learn More